Wells Fargo’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,415
| Closed | -$57.9K | – | 6645 |
|
|
2024
Q2 | $57.9K | Sell |
1,415
-21,026
| -94% | -$860K | ﹤0.01% | 4876 |
|
|
2024
Q1 | $949K | Buy |
22,441
+2,298
| +11% | +$97.1K | ﹤0.01% | 3172 |
|
|
2023
Q4 | $854K | Sell |
20,143
-29,629
| -60% | -$1.26M | ﹤0.01% | 3210 |
|
|
2023
Q3 | $1.09M | Sell |
49,772
-13,857
| -22% | -$302K | ﹤0.01% | 3030 |
|
|
2023
Q2 | $2.02M | Buy |
63,629
+2,759
| +5% | +$87.7K | ﹤0.01% | 2762 |
|
|
2023
Q1 | $1.48M | Buy |
60,870
+44,954
| +282% | +$1.1M | ﹤0.01% | 2917 |
|
|
2022
Q4 | $502K | Buy |
15,916
+13,905
| +691% | +$439K | ﹤0.01% | 3416 |
|
|
2022
Q3 | $57K | Sell |
2,011
-283
| -12% | -$8.02K | ﹤0.01% | 4597 |
|
|
2022
Q2 | $61K | Sell |
2,294
-7,394
| -76% | -$197K | ﹤0.01% | 4668 |
|
|
2022
Q1 | $339K | Sell |
9,688
-13,793
| -59% | -$483K | ﹤0.01% | 4395 |
|
|
2021
Q4 | $761K | Sell |
23,481
-23,388
| -50% | -$758K | ﹤0.01% | 4066 |
|
|
2021
Q3 | $1.38M | Buy |
+46,869
| New | +$1.38M | ﹤0.01% | 3764 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | – | – | 7174 |
|
|
2021
Q1 | $0 | Sell |
1
-239
| -100% | – | ﹤0.01% | 7095 |
|
|
2020
Q4 | $4K | Buy |
+240
| New | +$4K | ﹤0.01% | 5896 |
|